Contribution to the pathogenesis of dysmenorrhea

Area of Science:

• Reproductive Endocrinology
• Gynecology
• Biochemistry

Background:

• Dysmenorrhea, characterized by painful menstruation, affects a significant portion of women.
• Prostaglandins and steroid hormones play crucial roles in the menstrual cycle and uterine function.
• Previous research suggests a link between hormonal imbalances and the severity of menstrual pain.

Purpose of the Study:

• To investigate the relationship between prostaglandin levels (PGF2 alpha, PGE2, PGI2 metabolite), and steroid hormones (estradiol, estrone, progesterone) in women with and without dysmenorrhea.
• To identify potential hormonal markers associated with the pathophysiology of dysmenorrhea.

Main Methods:

• Collected menstrual blood samples from eumenorrheic and dysmenorrheic women over three cycles.
• Quantified levels of prostaglandin F2 alpha (PGF2 alpha), prostaglandin E2 (PGE2), 6-keto-prostaglandin F1 alpha (6-k-PGF1 alpha, prostacyclin metabolite), estradiol, estrone, and progesterone using radioimmunoassay.
• Analyzed blood loss, hormone concentrations, and prostaglandin ratios between the two groups.

Main Results:

• Dysmenorrheic women exhibited significantly elevated estradiol levels and a higher estradiol/progesterone ratio compared to eumenorrheic women.
• Menstrual PGF2 alpha levels were 2.5 times higher in dysmenorrheic women, while 6-k-PGF1 alpha (prostacyclin metabolite) levels were significantly lower.
• No significant differences were observed in blood loss or PGE2 levels between the groups.

Conclusions:

• A shift in the estradiol/progesterone ratio, favoring estradiol, appears to be a primary pathogenic factor in dysmenorrhea.
• Elevated PGF2 alpha and reduced PGI2 in uterine tissue likely contribute to the increased uterine activity and pain associated with dysmenorrhea.
• These hormonal and prostaglandin imbalances offer potential targets for understanding and managing dysmenorrhea.